BCG vaccination in children with severe combined immunodeficiency in a tertiary center: evaluation of complications and risks
Jornal de Pediatria · 2025
DOI: 10.1016/j.jped.2024.09.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jornal de Pediatria, 2025. Verfasst von Matheus Henrique Botaro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Pediatria, Divisão de Imunologia e Alergia Pediátrica, Ribeirão P…. Hauptthemen laut MEDLINE: BCG Vaccine, Severe Combined Immunodeficiency, Vaccination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVE: To describe the complications and risks associated with BCG (Bacillus Calmette-Guérin) vaccination in patients diagnosed with SCID (Severe Combined Immunodeficiency). METHODS: This is a descriptive case series study. Medical charts were retrospectively reviewed for demographics, clinical manifestation, laboratory findings at diagnosis, outcome, and diagnosis of BCG vaccine-associated complications. RESULTS: Eleven patients diagnosed with SCID were enrolled. Ten were male. Seven (64 %) were considered probable SCID, while four (36 %) were considered definite SCID (genetically confirmed). The median age at the onset of symptoms was one month; the median age at SCID diagnosis was four months. Respiratory symptoms were the most frequent. Eight patients were vaccinated within seven days of life. Seven (87 %) of these patients experienced BCG vaccine-associated complications (86 % disseminated reactions; 14 % localized reactions). BCG vaccine-associated complications were the first clinical manifestation in 75 % of the vaccinated patients. Less than half of the patients (36 %) underwent hematopoietic stem cell transplantation. The overall death rate was elevated (73 %); the death rate related to BCG vaccination was 25 %. CONCLUSIONS: Patients with SCID can present a high rate of BCG vaccine-associated complications, which negatively impact the clinical outcome and mortality. Pediatricians must be aware that BCG vaccine-associated complications can be the first presentation and a warning sign of SCID. Implementing newborn screening for SCID in Brazil may represent a worthy opportunity to impact the health outcomes of affected infants significantly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Pediatria, Divisão de Imunologia e Alergia Pediátrica, Ribeirão Preto, SP, Brazil.
- Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Pediatria, Divisão de Imunologia e Alergia Pediátrica, Ribeirão Preto, SP, Brazil. Electronic address: persiorj@fmrp.usp.br.
Zitieren
APA
Botaro, M. H., Maria E Silva, J., Jamra, S. R. A., Geraldino, S. Z., & Roxo-Junior, P. (2025). BCG vaccination in children with severe combined immunodeficiency in a tertiary center: evaluation of complications and risks. Jornal de Pediatria. https://doi.org/10.1016/j.jped.2024.09.008
Vancouver
Botaro MH, Maria E Silva J, Jamra SRA, Geraldino SZ, Roxo-Junior P. BCG vaccination in children with severe combined immunodeficiency in a tertiary center: evaluation of complications and risks. Jornal de Pediatria. 2025. doi:10.1016/j.jped.2024.09.008
BibTeX
@article{Botaro2025,
author = {Botaro, Matheus Henrique and Maria E Silva, Jorgete and Jamra, Soraya Regina Abu and Geraldino, Stephanie Zago and Roxo-Junior, Persio},
title = {BCG vaccination in children with severe combined immunodeficiency in a tertiary center: evaluation of complications and risks},
journal = {Jornal de Pediatria},
year = {2025},
doi = {10.1016/j.jped.2024.09.008}
}
EUVIMED